Key result
CABG offers a viable surgical alternative for severe ischemic cardiomyopathy when heart transplantation is unavailable.
Why the study?
Explicit clinical guidelines are lacking to guide surgeons in choosing among surgical options, including heart transplantation and revascularization, for ischemic cardiomyopathy patients with severe left ventricular dysfunction.
What are the available surgical management options and their long-term outcomes for patients with ischemic cardiomyopathy and severe left ventricular dysfunction?
What are the available surgical management options and their long-term outcomes for patients with ischemic cardiomyopathy and severe left ventricular dysfunction?
This review highlights the need for clear clinical guidelines and discusses alternative surgical options like CABG for ischemic cardiomyopathy patients with severe LV dysfunction when heart transplantation is not feasible.
Ischemic cardiomyopathy patients with severe left ventricular dysfunction are a specific group of patients with poor surgical outcomes. There are few surgical treatment options in practice for the treatment of these patients such as heart transplantation, coronary artery bypass surgery, surgical ventricular restoration, etc. Despite multiple treatment options, there are no explicit clinical guidelines available to guide surgeons in choosing the most appropriate option and ensuring that the specific patient can benefit from the selected surgical treatment. Heart transplantation is the gold standard treatment for ischemic cardiomyopathy patients with severe left ventricular dysfunction, but it is limited to very few highly equipped centers around the world due to donor shortages, complex perioperative and surgical management, and limited technological and human resources. It is evident from some studies that heart transplant-eligible candidates can benefit from alternative surgical options such as coronary artery bypass surgery alone or combined with surgical ventricular restoration. Therefore, alternative surgical options that are used for most of the population, especially in developing and underdeveloped countries, need to be discussed to improve their outcomes. A challenge in the recent era which has yet to find a solution is to determine which heart transplant candidate can benefit from simple revascularization compared to a complex heart transplantation procedure. Myocardial viability testing was one of the most important determinants in deciding whether a patient should undergo revascularization, but its role in guiding appropriate surgical options has been challenged. This review aims to discuss the available surgical management options and their long-term outcomes for patients with ischemic cardiomyopathy, which will eventually help surgeons when choosing a surgical procedure.
No takes yet. Share an insight, caveat, or question.
Masroor et al. (2024) conducted a review in Ischemic cardiomyopathy with severe left ventricular dysfunction. Surgical management (heart transplantation, coronary artery bypass surgery, surgical ventricular restoration) was evaluated. Alternative surgical options like coronary artery bypass surgery are discussed for ischemic cardiomyopathy patients with severe left ventricular dysfunction when heart transplantation is unavailable.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: